greeksoup/ stock research
Stock research / United States / NVS / Year to 31 December 2022

Novartis AG (NVS) annual results, year to 31 December 2022: revenue USD 42,206 million, from the 20-F

Novartis AG files a 20-F with the SEC once a year, in US dollars. In the year to 31 December 2022 it reported revenue from the sale of goods of USD 42,206 million, down 1.3% on the year before. Its profit attributable to shareholders was USD 6,955 million, down 71.0%, and diluted earnings per share USD 3.17.

Revenue
USD 42,206 million
-1.3% on the year
FY2016FY2022
Operating margin
18.8%
23.5% a year earlier
FY2016FY2022
Net income
USD 6,955 million
-71.0% on the year
FY2016FY2022
Diluted EPS
USD 3.17
-70.2% on the year
FY2016FY2022

this yearthe year beforeIn US dollars as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2021 †Dec 2022 †
Revenue from the sale of goods42,78142,206
Cost of sales11,73511,582
Gross profit32,23931,879
Research and development8,6419,172
Selling, general and administrative12,82712,193
Operating profit10,0567,946
Profit before tax24,5307,177
Income tax1,6251,128
Profit for the year24,0186,955
Profit attributable to shareholders24,0216,955
Filing20-F20-F
USD million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2021 †Dec 2022 †
Diluted EPS10.633.17
Basic EPS10.713.19
Filing20-F20-F

USD per ordinary share, as filed.

Cash flow

Year toDec 2021 †Dec 2022 †
Cash from operations15,07114,236
Purchase of property, plant and equipment1,066916
Free cash flow14,00513,320
Cash from investing4,2081,468
Cash from financing-16,264-20,562
Buybacks3,05710,652
Dividends paid7,3687,506
Filing20-F20-F

USD million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2021 †Dec 2022 †
Funded by
Equity attributable to shareholders67,65559,342
Non-controlling interests16781.0
Borrowings, as filed25,52322,485
Lease liabilities1,8961,789
Other liabilities36,55433,756
Total equity and liabilities131,795117,453
Owned
Property, plant and equipment11,54510,764
Goodwill29,59529,301
Other intangible assets34,18231,644
Cash and cash equivalents12,4077,517
Inventories6,6667,175
Other assets37,40031,052
Total assets131,795117,453
Filing20-F20-F

USD million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2021 †Dec 2022 †
Return on year-end equity35.5%11.7%
Effective tax rate6.6%15.7%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2022, filed 31 January 2025: the filing. The figures are in US dollars as filed.